Novato, CA, United States of America

Robert E Lovins


Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 31(Granted Patents)


Company Filing History:


Years Active: 1984

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovative Contributions of Robert E. Lovins

Introduction

Robert E. Lovins is a notable inventor based in Novato, California. He has made significant contributions to the field of biotechnology, particularly in the development of methods for obtaining specific antibodies. His work has implications for medical diagnostics and therapeutic applications.

Latest Patents

Robert E. Lovins holds a patent for a method of obtaining antibodies that are specific to glycosylated hemoglobin. This innovative approach involves administering a synthetic antigen to a host animal. The antigen consists of a glycosylated synthetic peptide that corresponds to the NH₂-terminus of the β-chain of hemoglobin. The peptide is designed to be between four and ten amino acids long, with a preference for seven amino acids. It is conjugated with glucose and a foreign protein, typically an immunoglobulin, to enhance the immune response.

Career Highlights

Lovins has dedicated his career to advancing the field of immunology through his research and inventions. His work at Sherwood Medical Company has allowed him to collaborate with other experts in the field, further enhancing the impact of his innovations.

Collaborations

Some of his notable coworkers include Louis M. Mezei and Jung S. Chen. Their collaborative efforts have contributed to the success of various projects and advancements in antibody research.

Conclusion

Robert E. Lovins exemplifies the spirit of innovation in biotechnology through his patented methods for antibody production. His contributions continue to influence the field and pave the way for future advancements in medical science.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…